Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study.
Saved in:
| Title: | Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study. |
|---|---|
| Authors: | Connor MJ; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: m.connor@imperial.ac.uk., Genie M; Health Economics Research Unit (HERU), Institute of Applied Health Science, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen, UK; Newcastle Business School, University of Newcastle, Newcastle, NSW, Australia; Department of Population Health Sciences, Duke University, Durham, USA., Dudderidge T; Urology, University Hospital Southampton, Southampton, UK., Wu H; Health Economics Research Unit (HERU), Institute of Applied Health Science, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen, UK., Sukumar J; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial College Clinical Trials Unit, Imperial College London, London, UK., Beresford M; Department of Oncology, Royal United Hospitals Bath, Bath, UK., Bianchini D; Department of Oncology and Urology, Medway Maritime Hospital, Kent, UK., Goh C; Department of Oncology, East Surrey Hospital, Redhill, UK., Horan G; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK., Innominato P; Department of Oncology, Betsi Cadwaladr University Health Board, Bangor, UK., Khoo V; Department of Oncology, The Royal Marsden Hospital, London, UK., Klimowska-Nassar N; Imperial College Clinical Trials Unit, Imperial College London, London, UK., Madaan S; Department of Urology, Dartford and Gravesham NHS Trust, Kent, UK., Mangar S; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., McCracken S; Department of Urology, Sunderland Royal Hospital, Sunderland, UK., Ostler P; Department of Oncology, Luton and Dunstable University Hospital, Luton, UK., Paisey S; Department of Oncology, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK., Robinson A; Department of Oncology, Royal Sussex County Hospital, Brighton, UK., Rai B; Department of Urology, Newcastle Freeman Hospital, Newcastle, UK., Sarwar N; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., Srihari N; Department of Oncology, Royal Shrewsbury Hospital, Shrewsbury, UK., Jayaprakash KT; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK., Varughese M; Department of Oncology, Royal Devon and Exeter NHS Foundation Trust, Oncology, Exeter, UK., Winkler M; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Department of Urology, West Middlesex University Hospital, London, UK., Ahmed HU; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Watson V; Health Economics Research Unit (HERU), Institute of Applied Health Science, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen, UK. |
| Corporate Authors: | IP5-MATTER Trial Investigators |
| Source: | European urology oncology [Eur Urol Oncol] 2025 Jun; Vol. 8 (3), pp. 663-673. Date of Electronic Publication: 2024 Jul 06. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
